Turning Point Therapeutics
Latest round
- Series C
Last raised
- May 2017
Total raised
- $45M
Investors
- 5
About Turning Point Therapeutics
Turning Point Therapeutics, Inc.Founded in 2013 and headquartered in San Diego, US, Turning Point Therapeutics, Inc. focuses on developing novel cancer therapeutics with a specific emphasis on targeted treatments.Turning Point Therapeutics, Inc. specializes in creating targeted therapies for cancer treatment, utilizing a range of innovative biological and small molecule therapies.In 2021, Turning Point Therapeutics, Inc.Looking forward, Turning Point Therapeutics, Inc. is strategically focused on expanding its product pipeline and geographic presence. This includes leveraging its acquisition by Bristol-Myers Squibb to facilitate entry into additional global regions, aiming to increase accessibility and availability of its innovative treatments.
Who invested in Turning Point Therapeutics
5 investors across 1 round
See all investors in Turning Point Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
May 23, 2017
Amount
$45M
Investors
Questions about Turning Point Therapeutics
Who invested in Turning Point Therapeutics?
Turning Point Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Turning Point Therapeutics raised?
Turning Point Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Turning Point Therapeutics last raise money?
Turning Point Therapeutics's most recent round on record is a Series C, in May 2017.
What does Turning Point Therapeutics do?
Turning Point Therapeutics, Inc.
Where is Turning Point Therapeutics headquartered?
Turning Point Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Turning Point Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Turning Point Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Turning Point Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.